Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Product Details for NDA 202278

ZECUITY (SUMATRIPTAN SUCCINATE)
EQ 6.5MG BASE/4HR
Marketing Status: Discontinued

Active Ingredient: SUMATRIPTAN SUCCINATE
Proprietary Name: ZECUITY
Dosage Form; Route of Administration: SYSTEM; IONTOPHORESIS
Strength: EQ 6.5MG BASE/4HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N202278
Product Number: 001
Approval Date: Jan 17, 2013
Applicant Holder Full Name: TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
Marketing Status: Discontinued
Patent and Exclusivity Information